AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 15857725 — intervention group
Group type: EXPERIMENTAL
Intervention: Weekly individual standardized interpersonal cognitive psychotherapy
Number of subjects: 90
Study 15857725 — intervention group
Group type: EXPERIMENTAL
Intervention: 16 mg buprenorphine every other day
Number of subjects: 90
Study 14694974 — intervention group
Group type: EXPERIMENTAL
Intervention: Porcine-derived lung surfactant therapy within the first hour of life (Group A, 35 neonates)
Number of subjects: 75
Study 14694974 — intervention group
Group type: COMPARATOR
Intervention: No surfactant therapy within the first hour of life (Group B, 40 neonates)
Number of subjects: 75
Study 14694974 — intervention group
Group type: EXPERIMENTAL
Intervention: Porcine-derived lung surfactant therapy within the first hour of life (Group A)
Number of subjects: 75
Study 14694974 — intervention group
Group type: COMPARATOR
Intervention: No surfactant therapy within the first hour of life (Group B)
Number of subjects: 75
Study 14694974 — intervention group
Group type: EXPERIMENTAL
Intervention: Weight of neonates
Number of subjects: 75
Study 11512056 — intervention group
Group type: EXPERIMENTAL
Intervention: RATG group 1
Number of subjects: 171
Study 11512056 — intervention group
Group type: COMPARATOR
Intervention: OKT3 group 1
Number of subjects: 171
Study 11512056 — intervention group
Group type: EXPERIMENTAL
Intervention: RATG group 2
Number of subjects: 171
Study 9663834 — intervention group
Group type: EXPERIMENTAL
Intervention: Pantoprazole 40 mg once daily
Number of subjects: 222
Study 17233169 — intervention group
Group type: EXPERIMENTAL
Intervention: Air-powder polishing for 60 seconds with Concise adhesive
Number of subjects: 96
Study 17233169 — intervention group
Group type: COMPARATOR
Intervention: Air-powder polishing for 0, 15, and 30 seconds with Concise adhesive
Number of subjects: 96
Study 17233169 — intervention group
Group type: EXPERIMENTAL
Intervention: Air-powder polishing for 60 seconds with System 1+ adhesive
Number of subjects: 96
Study 17233169 — intervention group
Group type: COMPARATOR
Intervention: Air-powder polishing for 0, 15, and 30 seconds with System 1+ adhesive
Number of subjects: 96
Study 2938515 — intervention group
Group type: EXPERIMENTAL
Intervention: Ipratropium bromide as inhalation powder (40 micrograms)
Number of subjects: 20
Study 2938515 — intervention group
Group type: COMPARATOR
Intervention: Ipratropium bromide as aerosol (2 puffs of 20 micrograms)
Number of subjects: 20
Study 31662373 — intervention group
Group type: EXPERIMENTAL
Intervention: Internet-Based Exercise programme (iBEAT-OA), 20-30 min daily for six weeks
Number of subjects: 134
Study 31662373 — intervention group
Group type: COMPARATOR
Intervention: Standard community care provided by general practitioners (GPs)
Number of subjects: 134
Study 30353809 — intervention group
Group type: EXPERIMENTAL
Intervention: 6 mg regular‐release melatonin
Number of subjects: 13
Study 30353809 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 13
Study 30353809 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients with Dravet syndrome
Number of subjects: 13
Study 27314121 — intervention group
Group type: EXPERIMENTAL
Intervention: Machined implants
Number of subjects: 50
Study 27314121 — intervention group
Group type: EXPERIMENTAL
Intervention: Roughened implants
Number of subjects: 50
Study 27314121 — intervention group
Group type: COMPARATOR
Intervention: Control (not explicitly mentioned)
Number of subjects: 50
Study 25081937 — intervention group
Group type: EXPERIMENTAL
Intervention: Cryotherapy (ice packs applied for a minimum of 24 hours)
Number of subjects: 55
Study 25081937 — intervention group
Group type: COMPARATOR
Intervention: No cryotherapy (control group)
Number of subjects: 55
Study 22067793 — intervention group
Group type: EXPERIMENTAL
Intervention: LNG/EE (90 mcg levonorgestrel/20 mcg ethinyl estradiol)
Number of subjects: 367
Study 22067793 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 367
Study 20420996 — intervention group
Group type: EXPERIMENTAL
Intervention: Kouk-Sun-Do (KSD) exercise, low-intensity, 45-minute sessions, three times a week for 16 weeks
Number of subjects: 39
Study 20420996 — intervention group
Group type: COMPARATOR
Intervention: Control group (no specific intervention mentioned)
Number of subjects: 39
Study 18798585 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.02% mitomycin-C applied intraoperatively for 3 minutes after pterygium excision
Number of subjects: 65
Study 18798585 — intervention group
Group type: COMPARATOR
Intervention: Topical 0.02% mitomycin-C drops twice a day for 2 weeks after pterygium excision
Number of subjects: 65
Study 15851601 — intervention group
Group type: EXPERIMENTAL
Intervention: Clopidogrel and Aspirin (dual therapy)
Number of subjects: 107
Study 15851601 — intervention group
Group type: COMPARATOR
Intervention: Aspirin monotherapy (control)
Number of subjects: 107
Study 11403068 — intervention group
Group type: EXPERIMENTAL
Intervention: Hirudin (10 micrograms/kg/h, adjusted in 2 micrograms/kg/h steps, targeted ECT 80-100 s)
Number of subjects: 17
Study 11403068 — intervention group
Group type: COMPARATOR
Intervention: Heparin (250 IU/h, adjusted in 125 IU/h steps, targeted ACT 180-210 s)
Number of subjects: 17
Study 9663728 — intervention group
Group type: EXPERIMENTAL
Intervention: famotidine 10 mg
Number of subjects: 24
Study 9663728 — intervention group
Group type: EXPERIMENTAL
Intervention: effervescent cimetidine 200 mg
Number of subjects: 24
Study 9663728 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 24
Study 7833101 — intervention group
Group type: EXPERIMENTAL
Intervention: Fadrozole hydrochloride 0.5 mg bd
Number of subjects: 80
Study 7833101 — intervention group
Group type: EXPERIMENTAL
Intervention: Fadrozole hydrochloride 1.0 mg bd
Number of subjects: 80
Study 7833101 — intervention group
Group type: EXPERIMENTAL
Intervention: Fadrozole hydrochloride 2.0 mg bd
Number of subjects: 80
Study 7833101 — intervention group
Group type: EXPERIMENTAL
Intervention: Fadrozole hydrochloride (all doses)
Number of subjects: 80
Study 7833101 — intervention group
Group type: EXPERIMENTAL
Intervention: Fadrozole hydrochloride
Number of subjects: 80
Study 3275684 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.3 mg cabergoline
Number of subjects: 51
Study 3275684 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.6 mg cabergoline
Number of subjects: 51
Study 3275684 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.6 mg cabergoline (twice weekly)
Number of subjects: 51
Study 3275684 — intervention group
Group type: COMPARATOR
Intervention: bromocriptine
Number of subjects: 51
Study 1489388 — intervention group
Group type: EXPERIMENTAL
Intervention: Methimazole for 18 months
Number of subjects: 168
Study 1489388 — intervention group
Group type: EXPERIMENTAL
Intervention: Subtotal thyroidectomy
Number of subjects: 168
Study 1489388 — intervention group
Group type: EXPERIMENTAL
Intervention: Iodine-131 therapy
Number of subjects: 168
Study 1489388 — intervention group
Group type: COMPARATOR
Intervention: Surgical treatment (group 2)
Number of subjects: 168
Study 1489388 — intervention group
Group type: COMPARATOR
Intervention: Medical treatment (group 2)
Number of subjects: 168
Study 860807 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral diazepam and metoclopramide with a drink
Number of subjects: 0
Study 860807 — intervention group
Group type: COMPARATOR
Intervention: Pethidine and atropine given intramuscularly without a drink
Number of subjects: 0
Study 31444252 — intervention group
Group type: EXPERIMENTAL
Intervention: calaspargase pegol‐mknl (CALASP), 2,500 U/m2 intravenously, every 3 weeks
Number of subjects: 124
Study 31444252 — intervention group
Group type: COMPARATOR
Intervention: calaspargase pegol‐mknl (CALASP)
Number of subjects: 124
Study 31880803 — intervention group
Group type: EXPERIMENTAL
Intervention: Bundled payments for hip and knee joint replacement operations
Number of subjects: 493977
Study 28425272 — intervention group
Group type: EXPERIMENTAL
Intervention: Washed red blood cells (WRBC) transfusion
Number of subjects: 38
Study 28425272 — intervention group
Group type: COMPARATOR
Intervention: Nonwashed red blood cells (NWRBC) transfusion
Number of subjects: 38
Study 26375928 — intervention group
Group type: EXPERIMENTAL
Intervention: Intranasal oxytocin (30 IU)
Number of subjects: 60
Study 26375928 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study 23147384 — intervention group
Group type: EXPERIMENTAL
Intervention: 5 mg day(‐1) GSK1521498
Number of subjects: 63
Study 23147384 — intervention group
Group type: EXPERIMENTAL
Intervention: 2 mg day(‐1) GSK1521498
Number of subjects: 63
Study 23147384 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 63
Study 21875814 — intervention group
Group type: EXPERIMENTAL
Intervention: C-arm CT/DSA (test group)
Number of subjects: 87
Study 21875814 — intervention group
Group type: COMPARATOR
Intervention: DSA (control group)
Number of subjects: 87
Study 19242709 — intervention group
Group type: EXPERIMENTAL
Intervention: Diclofenac suppositories
Number of subjects: 200
Study 19242709 — intervention group
Group type: COMPARATOR
Intervention: Indomethacin suppositories
Number of subjects: 200
Study 16758935 — intervention group
Group type: EXPERIMENTAL
Intervention: Xe:O2
Number of subjects: 60
Study 16758935 — intervention group
Group type: COMPARATOR
Intervention: N2O:O2+fentanyl
Number of subjects: 60
Study 15715628 — intervention group
Group type: EXPERIMENTAL
Intervention: Desflurane
Number of subjects: 160
Study 15715628 — intervention group
Group type: COMPARATOR
Intervention: Sevoflurane
Number of subjects: 160
Study 15715628 — intervention group
Group type: EXPERIMENTAL
Intervention: Desflurane and Sevoflurane
Number of subjects: 160
Study 11325669 — intervention group
Group type: EXPERIMENTAL
Intervention: Perindopril
Number of subjects: 42
Study 11325669 — intervention group
Group type: EXPERIMENTAL
Intervention: Nifedipine
Number of subjects: 42
Study 11325669 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 42
Study 9771218 — intervention group
Group type: EXPERIMENTAL
Intervention: Endoscopic ultrasound (EUS) for local tumour staging
Number of subjects: 90
Study 9771218 — intervention group
Group type: EXPERIMENTAL
Intervention: Endoscopic ultrasound (EUS) for lymph node staging
Number of subjects: 90
Study 9771218 — intervention group
Group type: COMPARATOR
Intervention: Endoscopic ultrasound (EUS) compared to other imaging modalities
Number of subjects: 90
Study 9771218 — intervention group
Group type: EXPERIMENTAL
Intervention: Fine needle aspiration biopsy using radial scanning EUS guidance
Number of subjects: 90
Study 8141609 — intervention group
Group type: EXPERIMENTAL
Intervention: 5‐MOPm plus UVA radiation
Number of subjects: 22
Study 8141609 — intervention group
Group type: COMPARATOR
Intervention: 5‐MOP
Number of subjects: 22
Study 3336100 — intervention group
Group type: EXPERIMENTAL
Intervention: Saline
Number of subjects: 75
Study 3336100 — intervention group
Group type: EXPERIMENTAL
Intervention: 2% lidocaine viscous solution
Number of subjects: 75
Study 3336100 — intervention group
Group type: EXPERIMENTAL
Intervention: Dilute surgical lubricant
Number of subjects: 75
Study 3336100 — intervention group
Group type: EXPERIMENTAL
Intervention: Upper ureteral stones
Number of subjects: 75
Study 3336100 — intervention group
Group type: EXPERIMENTAL
Intervention: Mid ureteral stones
Number of subjects: 75
Study 3336100 — intervention group
Group type: EXPERIMENTAL
Intervention: Lower ureteral stones
Number of subjects: 75
Study 3336100 — intervention group
Group type: EXPERIMENTAL
Intervention: Stones 0.5 cm or less
Number of subjects: 75
Study 3336100 — intervention group
Group type: EXPERIMENTAL
Intervention: Stones between 0.6 and 1.0 cm
Number of subjects: 75
Study 3336100 — intervention group
Group type: EXPERIMENTAL
Intervention: Stones larger than 1.0 cm
Number of subjects: 75
Study 3336100 — intervention group
Group type: EXPERIMENTAL
Intervention: Extracorporeal shock wave lithotripsy
Number of subjects: 75
Study 3336100 — intervention group
Group type: EXPERIMENTAL
Intervention: Percutaneous nephrostomy or ureteral meatotomy
Number of subjects: 75
Study 3336100 — intervention group
Group type: EXPERIMENTAL
Intervention: Repeat extracorporeal shock wave lithotripsy
Number of subjects: 75
Study 3336100 — intervention group
Group type: EXPERIMENTAL
Intervention: Pelvic stones
Number of subjects: 75
Study 29282731 — intervention group
Group type: EXPERIMENTAL
Intervention: TAU plus up to 16 sessions of individual formulation‐based CBT for ADHD
Number of subjects: 60
Study 29282731 — intervention group
Group type: COMPARATOR
Intervention: Treatment as usual (TAU)
Number of subjects: 60
Study 27612178 — intervention group
Group type: EXPERIMENTAL
Intervention: Individualized communication training for oncologists and question prompt lists with individualized communication coaching for patients
Number of subjects: 265
Study 27612178 — intervention group
Group type: COMPARATOR
Intervention: Control group received no training
Number of subjects: 265
Study 25633626 — intervention group
Group type: EXPERIMENTAL
Intervention: CyberSenga program
Number of subjects: 366
Study 25633626 — intervention group
Group type: COMPARATOR
Intervention: treatment-as-usual control group
Number of subjects: 366
Study 23615694 — intervention group
Group type: EXPERIMENTAL
Intervention: Aripiprazole once-monthly (ARI-OM)
Number of subjects: 403
Study 23615694 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 403
Study 22142991 — intervention group
Group type: EXPERIMENTAL
Intervention: Diet and Exercise (DE)
Number of subjects: 206
Study 22142991 — intervention group
Group type: COMPARATOR
Intervention: Diet Only (DO)
Number of subjects: 206
Study 19491792 — intervention group
Group type: EXPERIMENTAL
Intervention: Surgical treatment during hospitalization
Number of subjects: 177
Study 19491792 — intervention group
Group type: COMPARATOR
Intervention: Conservative therapy following stapedoplasty (1 year or more earlier)
Number of subjects: 177
Study 19491792 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined treatment with betahistine dihydrochloride (betaserk) during 2 months and 10-12 sessions of game exercises at a stabilographic complex
Number of subjects: 177
Study 17110823 — intervention group
Group type: EXPERIMENTAL
Intervention: Nontricyclic antidepressant
Number of subjects: 147
Study 15601962 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-carbohydrate diets
Number of subjects: 0
Study 15601962 — intervention group
Group type: COMPARATOR
Intervention: Low-fat diets
Number of subjects: 0
Study 11769814 — intervention group
Group type: EXPERIMENTAL
Intervention: Tryptophan loading
Number of subjects: 0
Study 11769814 — intervention group
Group type: COMPARATOR
Intervention: Tryptophan depletion
Number of subjects: 0
Study 9934406 — intervention group
Group type: EXPERIMENTAL
Intervention: Cetirizine (10 mg/die per os) + Placebo of fluticasone (2 puff per nostril once daily by aerosol) for 60 days
Number of subjects: 54
Study 9934406 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluticasone (100 mg per nostril once daily by aerosol) + Placebo of cetirizine (per os) for 60 days
Number of subjects: 54
Study 9934406 — intervention group
Group type: EXPERIMENTAL
Intervention: Cetirizine (10 mg/die per os) + Fluticasone (100 mg per nostril once daily by aerosol) for 20 days
Number of subjects: 54
Study 9934406 — intervention group
Group type: EXPERIMENTAL
Intervention: Both treatments (Cetirizine and Fluticasone)
Number of subjects: 54
Study 8148218 — intervention group
Group type: EXPERIMENTAL
Intervention: Colestipol 10 g daily (administered as 5 g twice daily or 10 g once daily)
Number of subjects: 98
Study 8148218 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 98
Study 3246466 — intervention group
Group type: EXPERIMENTAL
Intervention: Carbohydrate (CHO) solution
Number of subjects: 9
Study 3246466 — intervention group
Group type: COMPARATOR
Intervention: Placebo (PL) solution
Number of subjects: 9
Study 31305338 — intervention group
Group type: EXPERIMENTAL
Intervention: Methadone 5 mg
Number of subjects: 22
Study 31305338 — intervention group
Group type: EXPERIMENTAL
Intervention: Methadone 10 mg
Number of subjects: 22
Study 31305338 — intervention group
Group type: EXPERIMENTAL
Intervention: Buprenorphine 0.2 mg
Number of subjects: 22
Study 31305338 — intervention group
Group type: EXPERIMENTAL
Intervention: Buprenorphine 0.4 mg
Number of subjects: 22
Study 31305338 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 22
Study 29084540 — intervention group
Group type: EXPERIMENTAL
Intervention: Artemisinin-naphthoquine (AN)
Number of subjects: 231
Study 29084540 — intervention group
Group type: COMPARATOR
Intervention: Artemether-lumefantrine (AL)
Number of subjects: 231
Study 26104600 — intervention group
Group type: EXPERIMENTAL
Intervention: 100 mg canagliflozin
Number of subjects: 0
Study 26104600 — intervention group
Group type: EXPERIMENTAL
Intervention: 200 mg canagliflozin
Number of subjects: 0
Study 23871435 — intervention group
Group type: EXPERIMENTAL
Intervention: 10-month parenting program delivered to mothers, including group meetings and home visits focusing on hygiene, responsive feeding, play, communication, gentle discipline, and nutritious foods.
Number of subjects: 463
Study 23871435 — intervention group
Group type: EXPERIMENTAL
Intervention: 10-month parenting program delivered to mothers.
Number of subjects: 463
Study 23871435 — intervention group
Group type: COMPARATOR
Intervention: Control group received standard government care.
Number of subjects: 463
Study 21638329 — intervention group
Group type: COMPARATOR
Intervention: Ziprasidone (placebo-controlled trials)
Number of subjects: 0
Study 21638329 — intervention group
Group type: COMPARATOR
Intervention: Ziprasidone (active comparator trials with risperidone and olanzapine)
Number of subjects: 0
Study 19490477 — intervention group
Group type: EXPERIMENTAL
Intervention: Extensively hydrolyzed milk formula (HF)
Number of subjects: 80
Study 19490477 — intervention group
Group type: COMPARATOR
Intervention: Cow's milk‐based formula (CMF)
Number of subjects: 80
Study 16738349 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive Stimulation Therapy (CST) group intervention, twice weekly for 8 weeks
Number of subjects: 91
Study 16738349 — intervention group
Group type: COMPARATOR
Intervention: Treatment as usual
Number of subjects: 91
Study 15523313 — intervention group
Group type: EXPERIMENTAL
Intervention: High-grade residual stenosis
Number of subjects: 240
Study 15523313 — intervention group
Group type: COMPARATOR
Intervention: Low-medium-grade lesion
Number of subjects: 240
Study 11149032 — intervention group
Group type: EXPERIMENTAL
Intervention: Interferon-alpha 2b (10 million units, three times a week for 24 weeks)
Number of subjects: 71
Study 11149032 — intervention group
Group type: EXPERIMENTAL
Intervention: Interferon-alpha 2b
Number of subjects: 71
Study 9102064 — intervention group
Group type: EXPERIMENTAL
Intervention: Etidronate 400 mg once daily for 14 days followed by 76 days of 500 mg of elementary calcium once daily, repeated every 3 months.
Number of subjects: 80
Study 9102064 — intervention group
Group type: COMPARATOR
Intervention: Calcium 500 mg once daily.
Number of subjects: 80
Study 8263386 — intervention group
Group type: EXPERIMENTAL
Intervention: Bismuth iodoform paraffin paste (BIPP) pack
Number of subjects: 95
Study 8263386 — intervention group
Group type: EXPERIMENTAL
Intervention: Telfa pack
Number of subjects: 95
Study 8263386 — intervention group
Group type: COMPARATOR
Intervention: No pack
Number of subjects: 95
Study 8263386 — intervention group
Group type: EXPERIMENTAL
Intervention: Silastic nasal splint with BIPP
Number of subjects: 95
Study 8263386 — intervention group
Group type: COMPARATOR
Intervention: Silastic nasal splint without BIPP
Number of subjects: 95
Study 8263386 — intervention group
Group type: EXPERIMENTAL
Intervention: BIPP pack
Number of subjects: 95
Study 3896368 — intervention group
Group type: EXPERIMENTAL
Intervention: Short peri-operative antibiotic course
Number of subjects: 192
Study 3896368 — intervention group
Group type: COMPARATOR
Intervention: Control group (no antibiotic course)
Number of subjects: 192
Study 3896368 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 192
Study 31819863 — intervention group
Group type: EXPERIMENTAL
Intervention: Silicone gel treatment applied twice per day for two months on the surgical wound site.
Number of subjects: 64
Study 31819863 — intervention group
Group type: COMPARATOR
Intervention: Placebo (Vaseline) treatment applied twice per day for two months on the surgical wound site.
Number of subjects: 64
Study 29128898 — intervention group
Group type: EXPERIMENTAL
Intervention: Paclitaxel (P) added to doxorubicin/cyclophosphamide (AC)
Number of subjects: 1065
Study 29128898 — intervention group
Group type: EXPERIMENTAL
Intervention: Paclitaxel (P) added to doxorubicin/cyclophosphamide (AC) in RS low subgroup
Number of subjects: 1065
Study 29128898 — intervention group
Group type: EXPERIMENTAL
Intervention: Paclitaxel (P) added to doxorubicin/cyclophosphamide (AC) in RS intermediate subgroup
Number of subjects: 1065
Study 29128898 — intervention group
Group type: EXPERIMENTAL
Intervention: Paclitaxel (P) added to doxorubicin/cyclophosphamide (AC) in RS high subgroup
Number of subjects: 1065
Study 26703653 — intervention group
Group type: EXPERIMENTAL
Intervention: Color It Real Program (intervention)
Number of subjects: 192
Study 24337734 — intervention group
Group type: EXPERIMENTAL
Intervention: Fast-track surgery (FTS)
Number of subjects: 240
Study 24337734 — intervention group
Group type: COMPARATOR
Intervention: Traditional therapy
Number of subjects: 240
Study 22946455 — intervention group
Group type: EXPERIMENTAL
Intervention: Heat stress condition (50°C, 40% relative humidity)
Number of subjects: 16
Study 22946455 — intervention group
Group type: COMPARATOR
Intervention: Control condition (20°C, 40% relative humidity)
Number of subjects: 16
Study 19540451 — intervention group
Group type: EXPERIMENTAL
Intervention: White MTA
Number of subjects: 40
Study 19540451 — intervention group
Group type: EXPERIMENTAL
Intervention: Calcium aluminate cement
Number of subjects: 40
Study 19540451 — intervention group
Group type: COMPARATOR
Intervention: Positive control group
Number of subjects: 40
Study 19540451 — intervention group
Group type: COMPARATOR
Intervention: Negative control group
Number of subjects: 40
Study 17463218 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard breakfast containing fat as 30% of calories
Number of subjects: 12
Study 17463218 — intervention group
Group type: EXPERIMENTAL
Intervention: High-fat breakfast containing fat as 60% of calories
Number of subjects: 12
Study 17463218 — intervention group
Group type: COMPARATOR
Intervention: Fasting (overnight fast of 10 hours)
Number of subjects: 12
Study 17463218 — intervention group
Group type: EXPERIMENTAL
Intervention: All conditions (fed and fasted)
Number of subjects: 12
Study 15889513 — intervention group
Group type: EXPERIMENTAL
Intervention: Electro-acupuncture with strong stimulation
Number of subjects: 0
Study 15889513 — intervention group
Group type: COMPARATOR
Intervention: Medication (Control group I)
Number of subjects: 0
Study 15889513 — intervention group
Group type: COMPARATOR
Intervention: Conventional acupuncture (Control group II)
Number of subjects: 0